ES245396U - Dispositivo de inhalacion perfeccionado - Google Patents

Dispositivo de inhalacion perfeccionado

Info

Publication number
ES245396U
ES245396U ES1979245396U ES245396U ES245396U ES 245396 U ES245396 U ES 245396U ES 1979245396 U ES1979245396 U ES 1979245396U ES 245396 U ES245396 U ES 245396U ES 245396 U ES245396 U ES 245396U
Authority
ES
Spain
Prior art keywords
container
medicine
passage
discharge chamber
carrying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES1979245396U
Other languages
English (en)
Other versions
ES245396Y (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex Puerto Rico Inc
Original Assignee
Syntex Puerto Rico Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Puerto Rico Inc filed Critical Syntex Puerto Rico Inc
Publication of ES245396U publication Critical patent/ES245396U/es
Application granted granted Critical
Publication of ES245396Y publication Critical patent/ES245396Y/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Nozzles (AREA)

Abstract

Dispositivo de inhalación perfeccionado, formado por dos partes y accionado por la respiración para dispensar un medicamento en polvo desde un contenedor portador de medicamento en polvo, caracterizado porque la primera parte del dispositivo comprende un alojamiento alargado provisto de un paso para el movimiento del aire a través del mismo, un extremo de cuyo alojamiento es un extremo de salida apto para la introducción en la boca o conducto nasal del usuario, cuyo paso presenta un extremo de entrada que termina en una cámara de descarga situada en dicho extremo de salida de dicho alojamiento, siendo la sección del paso menor que la de la cámara de descarga, comprendiendo dicha primera parte medios receptores de la segunda para del dispositivo y la segunda parte comprende medios receptores del contenedor portador de medicamento y aptos para su recepción en forma deslizante por dichos medios receptores de dicha primera parte de manera que cuando se coloca un contenedor portador de medicamento en dichos medios receptores de contenedor de dicha segunda parte y las dos partes se mueven una con relación a otra, el extremo abierto del contenedor portador de medicamento se posiciona adyacente al extremo interno de la cámara de descarga, con lo que, durante la inhalación, una parte de aire que circula a través del paso fluye hacia el interior del contenedor portador de medicamento para dispensar el medicamento desde el contenedor.
ES1979245396U 1978-09-05 1979-09-04 Dispositivo de inhalacion perfeccionado Expired ES245396Y (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/939,615 US4227522A (en) 1978-09-05 1978-09-05 Inhalation device

Publications (2)

Publication Number Publication Date
ES245396U true ES245396U (es) 1979-12-16
ES245396Y ES245396Y (es) 1980-06-16

Family

ID=25473465

Family Applications (1)

Application Number Title Priority Date Filing Date
ES1979245396U Expired ES245396Y (es) 1978-09-05 1979-09-04 Dispositivo de inhalacion perfeccionado

Country Status (8)

Country Link
US (1) US4227522A (es)
BE (1) BE878602A (es)
BR (1) BR5901188U (es)
DE (1) DE7924611U1 (es)
ES (1) ES245396Y (es)
FR (1) FR2435254A1 (es)
IT (1) IT7953541V0 (es)
ZA (1) ZA794696B (es)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
GB9216038D0 (en) * 1992-07-28 1992-09-09 Bespak Plc Dispensing apparatus for powdered medicaments
EP0691864A4 (en) * 1993-03-03 1996-07-03 Tenax Corp MEDICINE CARRIER FOR DRY POWDER INHALER
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
US5505194A (en) * 1994-03-23 1996-04-09 Abbott Laboratories Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
FR2731911B1 (fr) * 1995-03-20 1997-08-14 Paul Seyvos Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
PT995457E (pt) 1995-12-07 2004-07-30 Jago Res Ag Bocal para um inalador para a distribuicao reiterada doseadamente de um po farmacologicamente seco
US7131441B1 (en) 1995-12-07 2006-11-07 Skyepharma Ag Inhaler for multiple dosed administration of a pharmacological dry powder
US5669378A (en) * 1995-12-21 1997-09-23 Pera; Ivo Inhaling device
US20030203036A1 (en) 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
CA2212430A1 (en) * 1997-08-07 1999-02-07 George Volgyesi Inhalation device
UA73924C2 (en) * 1998-10-09 2005-10-17 Nektar Therapeutics Device for delivering active agent formulation to lungs of human patient
DE29908593U1 (de) 1999-05-14 1999-07-22 Jago Research AG, Hergiswil Mundstück für einen Inhalator zur Abgabe eines Medikaments
HUP0300491A2 (en) 2000-02-28 2003-07-28 Vectura Ltd Improvements in or relating to the delivery of oral drugs
US6595210B2 (en) * 2000-11-27 2003-07-22 Unisia Jecs Corporation Inhalator for administering powder composition
GB2380410B (en) * 2001-10-05 2003-11-19 Alchemy Healthcare Ltd Apparatus for the nasal or oral delivery of a medicament
EP1483283A4 (en) 2002-03-13 2007-04-11 Signum Biosciences Inc MODULATION OF PROTEIN METHYLATION AND PHOSPHOPROTEIN PHOSPHATE
ITMO20020297A1 (it) * 2002-10-16 2004-04-17 Roberto Oliva Inalatore per preparati monodose in capsule.
US20060045849A1 (en) * 2004-08-24 2006-03-02 Farhan Taghizadeh Method of customizing the fragrance of nasal medications
PL370285A1 (pl) * 2004-09-23 2006-04-03 Glaxosmithkline Pharmaceuticals Spółka Akcyjna Inhalator proszkowy
WO2006084033A1 (en) 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
WO2007052154A2 (en) 2005-04-29 2007-05-10 University Of Medicine And Dentistry Of New Jersey Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
US9585932B2 (en) 2005-04-29 2017-03-07 Peter C. Dowling Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
US9345745B2 (en) * 2005-04-29 2016-05-24 Bo Wang Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
US20070049641A1 (en) * 2005-08-24 2007-03-01 Rabindra Tirouvanziam Methods for treating and monitoring inflammation and redox imbalance cystic fibrosis
US20090192227A1 (en) * 2005-08-24 2009-07-30 Rabindra Tirouvanziam N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
AU315527S (en) 2006-09-28 2007-08-03 Glaxo Group Ltd Inhalation device
US8741849B2 (en) * 2007-01-10 2014-06-03 Purdue Research Foundation Kinase inhibitors and uses thereof
EP2155228B1 (en) 2007-01-10 2014-04-02 Purdue Research Foundation Polypeptide inhibitors of hsp27 kinase and uses therefor
ES2648196T3 (es) 2008-02-07 2017-12-29 The University Of Washington Dispositivo aerosol circunferencial
WO2009143380A2 (en) * 2008-05-21 2009-11-26 Neurotez, Inc. Methods for treating progressive cognitive disorders related to neurofibrillary tangles
ES2929343T3 (es) * 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
DK2349310T3 (da) * 2008-10-20 2014-08-11 Moerae Matrix Inc Polypeptid til behandling eller forebyggelse af adhæsioner
WO2010054017A1 (en) * 2008-11-04 2010-05-14 Nikolaos Tezapsidis Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
EP2378875B1 (en) * 2008-12-10 2018-05-30 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
US8933217B2 (en) 2009-07-24 2015-01-13 Amazentis Sa Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders
WO2011017132A2 (en) * 2009-07-27 2011-02-10 Purdue Research, Foundation Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
EP4088769A1 (en) 2011-03-03 2022-11-16 Impel Pharmaceuticals Inc. Nasal drug delivery device
EP2696888B1 (en) 2011-04-12 2018-12-05 Moerae Matrix, Inc., Compositions and methods for preventing or treating pulmonary fibrosis
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
EP2701712B1 (en) 2011-04-25 2017-06-21 Cornell University Use of uridine and deoxyuridine to treat folate-responsive pathologies
JP6645735B2 (ja) 2011-05-09 2020-02-14 インペル ニューロファーマ インコーポレイテッド 鼻薬送達用ノズル
EP2589381B1 (en) 2011-11-04 2016-08-31 Rabindra Tirouvanziam Compositions for improving or preserving lung function in a patient with a pulmonary disorder
WO2013134636A1 (en) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
CA2883703C (en) 2012-09-04 2021-10-19 Eleison Pharmaceuticals, Llc Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
CA2909954C (en) 2013-04-28 2021-03-23 Impel Neuropharma, Inc. Medical unit dose container
US10207065B2 (en) 2013-07-12 2019-02-19 John H. Silva Mouthpiece for inhalers
AU2014318821B2 (en) 2013-09-10 2018-04-19 Board Of Regents Of The University Of Texas System Therapeutics targeting truncated Adenomatous Polyposis Coli (APC) proteins
US10336788B2 (en) 2014-04-17 2019-07-02 Moerae Matrix, Inc. Inhibition of cardiac fibrosis in myocardial infarction
USD748242S1 (en) 2014-07-11 2016-01-26 H. Stuart Campbell Inhaler mouthpiece
US10082496B2 (en) 2014-09-10 2018-09-25 Board Of Regents Of The University Of Texas System Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
KR20170083063A (ko) 2014-11-17 2017-07-17 모레 매트릭스 인코포레이티드 이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정의 예방 또는 치료용 조성물 및 방법
KR102674191B1 (ko) 2014-12-10 2024-06-11 하이퍼스템 에스에이 뇌암 줄기 세포의 성장, 이동 및 침습성 감소 그리고 뇌종양을 가진 환자의 생존 개선 방법 및 조성물
BR112017014737A2 (pt) 2015-01-08 2018-01-16 Moerae Matrix Inc formulação de peptídeos inibidores de mk2
CN107921082A (zh) 2015-03-12 2018-04-17 莫伊莱麦屈克斯公司 含有mk2抑制剂肽的组合物用于治疗非小细胞肺癌的用途
CA2987071A1 (en) 2015-06-10 2016-12-15 Hackensack University Medical Center Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
CN107949279A (zh) 2015-07-06 2018-04-20 得克萨斯系统大学评议会 可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物
AU2016292779B2 (en) 2015-07-15 2021-05-20 The Board Of Regents Of The University Of Texas System Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
MA42708A (fr) 2015-09-10 2018-07-04 Impel Neuropharma Inc Dispositif d'administration nasale en ligne
US11833118B2 (en) 2016-01-20 2023-12-05 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
EP3405175A4 (en) 2016-01-20 2019-09-25 Flurry Powders, LLC Encapsulation of Lipophilic Ingredients in Dispersible Aerosol Powder Incorporated Powder
CA3081680A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with inlet interface
EP3713628A4 (en) 2017-11-21 2021-08-18 Impel Neuropharma Inc. INTRA-NASAL DEVICE WITH DIVER TUBE
AU2019205329B2 (en) 2018-01-05 2023-04-20 Impel Pharmaceuticals Inc. Intranasal delivery of olanzapine by precision olfactory device
KR20200118032A (ko) 2018-01-05 2020-10-14 임펠 뉴로파마 인코포레이티드 정밀 후각기관 장치에 의한 디하이드로에르고타민의 비강내 전달
WO2020018959A1 (en) 2018-07-19 2020-01-23 Impel Neuropharma, Inc. Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease
CN113473967B (zh) 2019-01-03 2022-09-09 英倍尔制药公司 经鼻药物递送装置
KR20220010011A (ko) 2019-05-17 2022-01-25 임펠 뉴로파마 인코포레이티드 일회용 비강 전달 장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2587215A (en) * 1949-04-27 1952-02-26 Frank P Priestly Inhalator
IT1017153B (it) * 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
GB1521000A (en) * 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
GB1598081A (en) * 1977-02-10 1981-09-16 Allen & Hanburys Ltd Inhaler device for dispensing medicaments

Also Published As

Publication number Publication date
BE878602A (fr) 1980-03-05
ZA794696B (en) 1981-04-29
DE7924611U1 (de) 1979-11-29
US4227522A (en) 1980-10-14
ES245396Y (es) 1980-06-16
IT7953541V0 (it) 1979-08-29
BR5901188U (pt) 1980-06-17
FR2435254A1 (fr) 1980-04-04

Similar Documents

Publication Publication Date Title
ES245396U (es) Dispositivo de inhalacion perfeccionado
US2587215A (en) Inhalator
US4192309A (en) Inhalation device with capsule opener
CA1054479A (en) Inhalation device
US3964483A (en) Inhalation device
FI88678B (fi) Inhalator
UA26276C2 (uk) Одhоразовий іhгалятор
RU93032035A (ru) Устройство для ингаляции
DE69215994D1 (de) Inhalator
RU94040868A (ru) Ингалятор одноразового использования
ES532735A0 (es) Dispositivo de administracion para uso medico
DE69211450D1 (de) Inhalator zur Verabreichung von pulverförmigen Substanzen
MXPA03010668A (es) Dispositivo e inhalacion.
DK0773807T3 (da) Inhalator
RU95101381A (ru) Способ ожижения порошкообразного лекарственного препарата для ингаляции, ингалятор
ATA227285A (de) Inhalationsgeraet zur dosierung und verteilung von festkoerpern in die atemluft
EE03225B1 (et) Seade osakeste kujul oleva materjali dispenseerimiseks üksikute dooside kaupa
DE3770460D1 (de) Inhalator.
ATE130771T1 (de) Inhalator.
SU1591990A1 (ru) Уctpoйctbo для bbeдehия лekapctbehhыx пopoшkob
US2241356A (en) Thermoinhaler
US2609817A (en) Inhaler
US1442253A (en) Inhaling apparatus
US3189030A (en) Inhaling device
TH25418A (th) "อุปกรณ์ที่ใช้กับจมูก"

Legal Events

Date Code Title Description
FD1K Utility model lapsed

Effective date: 19980601